Clinical trial
PET Scan in Treating Patients With Metastatic Prostate Cancer
NCT00002981 · Memorial Sloan Kettering Cancer Center, Other · Completed
Key facts
| NCT number | NCT00002981 |
|---|---|
| Title | PET Scan in Treating Patients With Metastatic Prostate Cancer |
| Official title | 11C-Methionine and 2-18F-Fluoro-2-Deoxy-D-Glucose PET Imaging in Patients With Progressive Prostate Cancer |
| Lead sponsor | Memorial Sloan Kettering Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Procedure, Radiation |
| Interventions | positron emission tomography, fludeoxyglucose F 18, methionine C 11 |
| Enrollment | 173 |
| Start date | Jan 1, 1997 |
| Primary completion | Jun 12, 2023 |
| Completion | Jun 12, 2023 |
| First posted | Jan 27, 2003 |
| Last update posted | Jun 3, 2024 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: